Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the successful conclusion of the eleventh Annual Genedata Partner Symposium (March 31?April 1 ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price boosted by Royal Bank of Canada from $408.00 to $420.00 in a research report sent to investors on Tuesday morning,Benzinga ...

Beyond computer science laboratories and the big Silicon Valley companies, artificial intelligence is now becoming more ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

SpaceX launched the private Fram2 mission Monday (March 31), sending a crew of four spaceflight rookies into an orbit never ...

Trump's upcoming tariffs has the potential to bring biopharma manufacturing to the US, which could impact companies with ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.

The cloud giant AI wars are heating up with Google announcing its Gemini 2.5 model and Amazon countering with the launch of ...

We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look ...